Related Experiment Video
Updated: Nov 4, 2025
06:26
Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
Published on: July 28, 2023
2.6K
Where are the RNA vaccines for TB?
Xiao-Yong Fan1, Douglas Bruce Lowrie1
1TB Center, Shanghai Emerging and Re-emerging Institute, Shanghai Public Health Clinical Center and Key Laboratory of Medical Molecular Virology of MOE/MOH, Fudan University, Shanghai, People's Republic of China.
Emerging Microbes & Infections
|May 26, 2021
Summary
Messenger RNA (mRNA) vaccines, successful against COVID-19, show promise for tuberculosis (TB) prevention. Early research in mice demonstrated mRNA vaccine efficacy against TB, suggesting potential for a new global health strategy.
Area of Science:
- Immunology
- Vaccinology
- Infectious Diseases
Background:
- Tuberculosis (TB) is a significant global health threat, causing over a million deaths annually.
- Like COVID-19, TB is a respiratory infection requiring urgent public health interventions.
- Existing TB vaccines have limitations in efficacy and duration of protection.
Purpose of the Study:
- To explore the potential of messenger RNA (mRNA) vaccination for tuberculosis (TB) prevention.
- To assess if the success of COVID-19 mRNA vaccines can be translated to TB control.
- To review historical data on mRNA vaccine efficacy in preclinical TB models.
Main Methods:
- Review of preclinical studies investigating mRNA vaccine candidates for TB.
- Analysis of historical data on mouse models of TB protection using mRNA vaccines.
- Comparative assessment of mRNA vaccine technology for respiratory pathogens.
Main Results:
- A simple mRNA vaccine demonstrated protective effects against tuberculosis in mice over 15 years ago.
- The historical data suggests a viable platform for developing novel TB vaccines.
- mRNA technology has proven effective for rapid vaccine development and deployment.
Conclusions:
- Messenger RNA vaccine technology holds significant promise for developing an effective tuberculosis vaccine.
- Replicating the success of COVID-19 mRNA vaccines for TB could address a critical global health emergency.
- Further research and development are warranted to advance mRNA-based TB vaccines towards clinical application.
Related Concept Videos
01:26Pulmonary Tuberculosis IV
251
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
251
01:28Pulmonary Tuberculosis V
287
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
287
01:29Pulmonary Tuberculosis I
446
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
446
01:28Pulmonary Tuberculosis II
784
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
784
01:31Pulmonary Tuberculosis III
563
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
563
01:51Vaccinations
48.3K
Overview
48.3K